Lin Wu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 35

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of cancer

Thoracic cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jianjiao Ni, Xiaofei Wang, Lin Wu, Xinghao Ai, Qian Chu, Chengbo Han, Xiaorong Dong, Yue Zhou, Yechun Pang, Zhengfei Zhu
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial. Nature communications 15 (1) (2024)
Jianjiao Ni, Xiaofei Wang, Lin Wu, Xinghao Ai, Qian Chu, Chengbo Han, Xiaorong Dong, Yue Zhou, Yechun Pang, Zhengfei Zhu
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial. Nature communications 15 (1) (2024)
Jin-Ji Yang, Yan Zhang, Lin Wu, Jie Hu, Zhe-Hai Wang, Jing-Hua Chen, Yun Fan, Gen Lin, Qi-Ming Wang, Yu Yao, Jun Zhao, Yuan Chen, Jian Fang, Yong Song, Wei Zhang, Ying Cheng, Ren-Hua Guo, Xing-Ya Li, He-Peng Shi, Wei-Zhe Xue, Di Han, Pei-Long Zhang, Yi-Long Wu
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tony S K Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin F Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Yang
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tony S K Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin F Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Yang
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Jingyi Wang, Lin Wu
First-line immunotherapy for advanced non-small cell lung cancer: current progress and future prospects. Cancer biology & medicine 21 (2) (2024)
Tony S K Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin F Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Yang
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer 15 (16) (2024)
Jieran Long, Xuefei Li, Lin Wu, Guohua Yu, Aimin Zang, Yanqiu Zhao, Jinsheng Shi, Ligong Nie, Xuan Zhao, Jian Fang
Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second-line monotherapy for patients with small-cell lung cancer. Cancer medicine 13 (17) (2024)
Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer 15 (16) (2024)
Jianjiao Ni, Xiaofei Wang, Lin Wu, Xinghao Ai, Qian Chu, Chengbo Han, Xiaorong Dong, Yue Zhou, Yechun Pang, Zhengfei Zhu
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial. Nature communications 15 (1) (2024)
Tony S K Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin F Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Yang
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Tony S K Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin F Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Yang
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer (2024)
Tony S K Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin F Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Yang
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer 15 (16) (2024)
Jingyi Wang, Lin Wu
First-line immunotherapy for advanced non-small cell lung cancer: current progress and future prospects. Cancer biology & medicine 21 (2) (2024)
Tony S K Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin F Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Yang
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ying Cheng, Dingzhi Huang, Jianying Zhou, Chengzhi Zhou, Yuping Sun, Lin Wu, Ye Guo, Shao Jingxin, Wanli Zhang, Shun Lu
Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial. JCO precision oncology 7 (2023)
Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer. British journal of cancer 130 (3) (2023)
Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer. British journal of cancer 130 (3) (2023)
Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer. British journal of cancer 130 (3) (2023)
Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer. British journal of cancer (2023)
Jingyi Wang, Lin Wu
First-line immunotherapy for advanced non-small cell lung cancer: current progress and future prospects. Cancer biology & medicine (2023)
Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer. British journal of cancer 130 (3) (2023)
Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer. British journal of cancer 130 (3) (2023)
Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer. British journal of cancer 130 (3) (2023)
Wenying Peng, Bin Li, Jin Li, Lianpeng Chang, Jing Bai, Yuting Yi, Rongrong Chen, Yanyan Zhang, Chen Chen, Xingxiang Pu, Meilin Jiang, Jia Li, Rui Zhong, Fang Xu, Bolin Chen, Li Xu, Ning Wang, Jiaojiao Huan, Pingping Dai, Yanfang Guan, Ling Yang, Xuefeng Xia, Xin Yi, Jiayin Wang, Fenglei Yu, Lin Wu
Clinical and genomic features of Chinese lung cancer patients with germline mutations. Nature communications 13 (1) (2022)
Zhijie Wang, Lin Wu, Baolan Li, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qi-Ming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, An-Wen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Li-Yun Miao, Zhihong Zhang, Hui Zhao, Jun Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Shi Jin, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng, Sheng Yao, Patricia Keegan, Jie Wang
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Yuan-Kai Shi, Lin Wu, Xinmin Yu, Puyuan Xing, Yan Wang, Jianying Zhou, Airong Wang, Jianhua Shi, Yi Hu, Ziping Wang, Guangyu An, Yong Fang, Sanyuan Sun, Cai-Cun Zhou, Changli Wang, Feng Ye, Xingya Li, Junye Wang, Mengzhao Wang, Yunpeng Liu, Yanqiu Zhao, Ying Yuan, Jifeng Feng, Zhendong Chen, Jindong Shi, Tao Sun, Gang Wu, Yongqian Shu, Qisen Guo, Yi Zhang, Yong Song, Shucai Zhang, Yuan Chen, Wei Li, Hongrui Niu, Wenwei Hu, Lijun Wang, Jianan Huang, Yang Zhang, Ying Cheng, Zhengdong Wu, Bo Peng, Jiya Sun, Christoph Mancao, Yanqi Wang, Luyao Sun
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3). Cancer communications (London, England) (2022)
Wenying Peng, Liming Cao, Likun Chen, Gen Lin, Bo Zhu, Xiaohua Hu, Yingcheng Lin, Sheng Zhang, Meilin Jiang, Jingyi Wang, Junjun Li, Chao Li, Lin Shao, Haiwei Du, Ting Hou, Zhiqiu Chen, Jianxing Xiang, Xingxiang Pu, Jia Li, Fang Xu, Herbert Loong, Lin Wu
Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901). The oncologist 27 (2) (2022)
Jingyi Wang, Lin Wu
An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer. Expert opinion on pharmacotherapy 23 (6) (2022)
Xingxiang Pu, QianZhi Wang, Liyu Liu, Bolin Chen, Kang Li, Yu Zhou, Zengmei Sheng, Ping Liu, Yucheng Tang, Li Xu, Jia Li, Yi Kong, Fang Xu, Yan Xu, Lin Wu
Rh-endostatin plus camrelizumab and chemotherapy in first-line treatment of advanced non-small cell lung cancer: A multicenter retrospective study. Cancer medicine (2022)
Qing Zhou, Lin Wu, Pei Hu, Tongtong An, Jianying Zhou, Li Zhang, Xiao-Qing Liu, Feng Luo, Xin Zheng, Ying Cheng, Nong Yang, Junling Li, Jifeng Feng, Baohui Han, Yong Song, Kai Wang, Li Zhang, Jian Fang, Hong Zhao, Yongqian Shu, Xiao-Yan Lin, Zhihong Chen, Bin Gan, Wan-Hong Xu, Wei Tang, Xiaoying Zhang, Jin-Ji Yang, Xiao Xu, Yi-Long Wu
A novel third generation EGFR tyrosine kinase inhibitor Abivertinib for EGFR T790M mutant Non-Small Cell Lung Cancer: a multicenter phase1/2 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-Yang Liu, Qing Zhou, Yi-Long Wu
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)